Kentucky Rescinds Dextrophan Positives: Blood-Horse 2/21/17

By: Frank Angst Citing new research that suggests the metabolite of Dextromethorphan, Dextrorphan, can stay in a horse's system at a wider variance of time than previously realized, the Kentucky Horse Racing Commission earlier this year dropped sanctions in three cases where the metabolite was discovered. KHRC equine medical director Mary Scollay offered a presentation

With Eye Toward Uniformity, Kentucky Reviews Drug Rules: Blood-Horse 2/1/17

By: Frank Angst After an in-depth review of its racing medication rules relative to the Association of Racing Commissioners International’s recommendations, a Kentucky council is recommending penalty classification changes for a pair of medications. The Kentucky Equine Drug Research Council recommended Feb. 1 that the expectorant ambroxol (Ambril) be moved to a more severe penalty

AAEP Announces Initiative to Enhance Horse Health, Racing Integrity: AAEP.org 7/28/15

Press release AAEP Announces Initiative to Enhance Horse Health, Racing Integrity Prescription for Racing Reform to seek non-race day EIPH treatments, support 48-hour NSAID rule The American Association of Equine Practitioners today announced a multi-part initiative to protect the health and welfare of the racehorse and help ensure the long-term viability of the racing industry

Anabolic Steroids Still Issue in U.S. Racing: The Blood-Horse 2/12/15

By Frank Angst Through the first 10 months of 2014, U.S. horse racing appeared on pace to register its fewest positive drug tests for anabolic steroids since the industry moved to outlaw the drugs from racing in 2008-09. But six positives for the anabolic steroid stanozolol from Nov. 19 to Dec. 19 at Laurel Park